Drug Database
L04 IMMUNOSUPPRESSANTS
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- L04AA03 antilymphocyte immunoglobulin (horse)
- L04AA04 antithymocyte immunoglobulin (rabbit)
- L04AA06 mycophenolic acid
- L04AA24 abatacept
- L04AA25 eculizumab
- L04AA28 belatacept
- L04AA32 apremilast
- L04AA40 cladribine
- L04AA41 imlifidase
- L04AA48 belumosudil
- L04AA58 efgartigimod alfa
- L04AB01 etanercept
- L04AB02 infliximab
- L04AB04 adalimumab
- L04AB05 certolizumab pegol
- L04AB06 golimumab
- L04AC02 basiliximab
- L04AC03 anakinra
- L04AC05 ustekinumab
- L04AC07 tocilizumab
- L04AC08 canakinumab
- L04AC10 secukinumab
- L04AC11 siltuximab
- L04AC12 brodalumab
- L04AC13 ixekizumab
- L04AC14 sarilumab
- L04AC16 guselkumab
- L04AC17 tildrakizumab
- L04AC18 risankizumab
- L04AC21 bimekizumab
- L04AC22 spesolimab
- L04AC24 mirikizumab
- L04AD01 ciclosporin
- L04AD02 tacrolimus
- L04AD03 voclosporin
- L04AE01 fingolimod
- L04AE03 siponimod
- L04AE04 ponesimod
- L04AE05 etrasimod
- L04AF01 tofacitinib
- L04AF02 baricitinib
- L04AF03 upadacitinib
- L04AF04 filgotinib
- L04AF07 deucravacitinib
- L04AF08 ritlecitinib
- L04AG03 natalizumab
- L04AG04 belimumab
- L04AG05 vedolizumab
- L04AG06 alemtuzumab
- L04AG08 ocrelizumab
- L04AG12 ofatumumab
- L04AH01 sirolimus
- L04AH02 everolimus
- L04AJ01 eculizumab
- L04AJ02 ravulizumab
- L04AJ03 pegcetacoplan
- L04AJ05 avacopan
- L04AK01 leflunomide
- L04AK02 teriflunomide
- L04AX01 azathioprine
- L04AX02 thalidomide
- L04AX03 methotrexate
- L04AX04 lenalidomide
- L04AX05 pirfenidone
- L04AX06 pomalidomide
- L04AX07 dimethyl fumarate
- L04AX08 darvadstrocel
- L04AX09 diroximel fumarate
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).